Brite |
KEGG Orthology (KO) [BR:ko00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
09130 Environmental Information Processing
09132 Signal transduction
04371 Apelin signaling pathway
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04024 cAMP signaling pathway
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04022 cGMP-PKG signaling pathway
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
09150 Organismal Systems
09152 Endocrine system
04910 Insulin signaling pathway
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04922 Glucagon signaling pathway
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04923 Regulation of lipolysis in adipocytes
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04914 Progesterone-mediated oocyte maturation
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
04924 Renin secretion
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
09160 Human Diseases
09165 Substance dependence
05032 Morphine addiction
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
Enzymes [BR:ko01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B
|
Authors |
Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M |